POWERED BY BIOHM - Trademark Details
Status: 734 - Fifth Extension - Granted
Serial Number
87757230
Word Mark
POWERED BY BIOHM
Status
734 - Fifth Extension - Granted
Status Date
2021-08-09
Filing Date
2018-01-16
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2018-12-25
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
SMITH, CYNTHIA RINALDI
Statements
Goods and Services
Food products containing probiotic compositions, namely, probiotic bacteria and probiotic bacterial cultures for use as a food additive for food manufacturing; human food products containing probiotic compositions, namely, probiotic bacteria and probiotic bacterial cultures for use as a food additive for food manufacturing; animal food products containing probiotic compositions, namely, nutritional additives for use in manufacturing animal feed
Goods and Services
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humans, namely, reducing inflammation and pain; dietary supplements for medical use, and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplements, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; beverages containing probiotic compositions for use as a nutritional supplement; food supplements containing probiotic compositions; human food supplements products containing probiotic compositions; animal food products containing probiotic compositions, namely, probiotic animal feed; dietary supplement drink mixes, namely, probiotic compositions in the form of mixes to added to beverages; dietary supplements in the nature of probiotic compositions for mixing with cereal
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2018-10-26
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-01-29
Primary Code
005
Current Trademark Owners
Party Name
Party Type
21 - 1st New Owner After Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
21 - 1st New Owner After Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Brian E. Turung
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2018-01-29 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-04-26 | ASSIGNED TO EXAMINER |
2018-04-30 | NON-FINAL ACTION WRITTEN |
2018-04-30 | NON-FINAL ACTION E-MAILED |
2018-04-30 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-10-26 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-10-26 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-10-26 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2018-10-28 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2018-11-12 | ASSIGNED TO LIE |
2018-12-05 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2018-12-25 | PUBLISHED FOR OPPOSITION |
2018-12-25 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-01-30 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
2019-02-19 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2019-08-16 | TEAS EXTENSION RECEIVED |
2019-08-16 | EXTENSION 1 FILED |
2019-08-16 | EXTENSION 1 GRANTED |
2019-08-20 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-02-18 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-02-18 | TEAS EXTENSION RECEIVED |
2020-02-27 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2020-02-18 | EXTENSION 2 FILED |
2020-02-27 | EXTENSION 2 GRANTED |
2020-02-28 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-08-19 | TEAS EXTENSION RECEIVED |
2020-08-19 | EXTENSION 3 FILED |
2020-08-19 | EXTENSION 3 GRANTED |
2020-08-21 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-10-05 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2020-10-05 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2020-10-05 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-10-05 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-10-05 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2021-02-15 | TEAS EXTENSION RECEIVED |
2021-02-15 | EXTENSION 4 FILED |
2021-02-15 | EXTENSION 4 GRANTED |
2021-02-17 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-07-28 | TEAS EXTENSION RECEIVED |
2021-08-06 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2021-07-28 | EXTENSION 5 FILED |
2021-08-09 | EXTENSION 5 GRANTED |
2021-08-10 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |